Clinical Trial Update: A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial to evaluate disease activity and safety of Lutikizumab in adults and adolescents with moderate to severe hidradenitis suppurativa, now …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Lutikizumab (lutikizumab)

Snippet

Sponsor: AbbVie | Conditions: Hidradenitis Suppurativa | Phase 3 | Status: RECRUITING